Phenestra's latest white paper highlights the challenges in market access and reimbursement for every company involved in developing new and innovative drugs.View info
Today, every pharmaceutical company has the patient...
As online doctor networks have grown they have also developed their own rules around how members interact, what sort of information they are looking for and how they like to... View info
As the UK health and social care systems look to improve patient services in the primary care setting, attention must turn to how carers, an army of around 6.5 million... View info
The personalised medicine approach is rapidly becoming the new norm for pharmaceutical industry drug development and commercialisation, but it demands much more forward-thinking decision-making, as Phenestra outlines in its latest... View info